Sensing Tool Measures Lung Function over the Phone
|
By HospiMedica International staff writers Posted on 12 May 2016 |

Image: A person using SpiroCall on a phone with and without a SpiroCall whistle (Photo courtesy of the University of Washington).
A new device allows lung function to be assessed from any phone, using the voice channel to transmit the sound of the spirometry effort.
Developed by researchers at the University of Washington (UW; Seattle, USA), the SpiroCall is a service that transmits an audio signal using the standard voice telephony channel. A server receives the data of degraded audio quality, calculates clinically relevant lung function measures using multiple regression algorithms, and reports the results using an audio message, text message, or both. The researchers also found several significant usability challenges more difficult to mitigate, such as how a user holds the phone, the distance from the user’s mouth to the phone, and how wide a user opens their mouth.
The researchers therefore designed a simple, low-cost 3D printed whistle accessory, which generates vortices as the user exhales through it, changing its resonating pitch in proportion to the flow rate. The whistle does not have any moving parts and is as simple as any spirometer mouthpiece. Advantages of the whistle include more consistent acoustic properties, audible sound at lower flow rates, removing the effect of distance from the user’s mouth, and precisely controlling mouth shape and phone orientation.
In a study to investigate viability of the call-in service approach with and without the whistle, the researchers evaluated SpiroCall in 50 patients, comparing it to approved spirometers and evaluating the effect of using the voice communication channel on performance. Each patient performed spirometry efforts with and without the whistle on two different phones, recording the audio through the cell phone network, and two smartphones recording the audio locally through an app. Participants also used two different sizes of vortex whistles to determine if different sizes work better for different individuals.
The results show that without a whistle, SpiroCall has a mean error of 7.2% for the four major clinically relevant lung function measures; for forced expiratory volume percentage (FEV1%), the mean error is 6.2%. With a whistle, SpiroCall has a mean error of 8.3% for the four measures, and 7.3% for FEV1%. Although the whistle shows higher average error in lung function estimates, it is more consistent for people with lower lung function and produces fewer overestimations. The study was presented at the Association for Computing Machinery conference, held during May 2016 in San Jose (CA, USA).
"People have to manage chronic lung diseases for their entire lives, so there's a real need to have a device that allows patients to accurately monitor their condition at home without having to constantly visit a medical clinic,” said lead author Mayank Goel, MSc, a computer science and engineering doctoral student. “Because this project has been around for four years, we've been able to talk to a lot of patients about how they're able to use the technology, and that feedback has really helped us make smart improvement.”
Related Links:
University of Washington
Developed by researchers at the University of Washington (UW; Seattle, USA), the SpiroCall is a service that transmits an audio signal using the standard voice telephony channel. A server receives the data of degraded audio quality, calculates clinically relevant lung function measures using multiple regression algorithms, and reports the results using an audio message, text message, or both. The researchers also found several significant usability challenges more difficult to mitigate, such as how a user holds the phone, the distance from the user’s mouth to the phone, and how wide a user opens their mouth.
The researchers therefore designed a simple, low-cost 3D printed whistle accessory, which generates vortices as the user exhales through it, changing its resonating pitch in proportion to the flow rate. The whistle does not have any moving parts and is as simple as any spirometer mouthpiece. Advantages of the whistle include more consistent acoustic properties, audible sound at lower flow rates, removing the effect of distance from the user’s mouth, and precisely controlling mouth shape and phone orientation.
In a study to investigate viability of the call-in service approach with and without the whistle, the researchers evaluated SpiroCall in 50 patients, comparing it to approved spirometers and evaluating the effect of using the voice communication channel on performance. Each patient performed spirometry efforts with and without the whistle on two different phones, recording the audio through the cell phone network, and two smartphones recording the audio locally through an app. Participants also used two different sizes of vortex whistles to determine if different sizes work better for different individuals.
The results show that without a whistle, SpiroCall has a mean error of 7.2% for the four major clinically relevant lung function measures; for forced expiratory volume percentage (FEV1%), the mean error is 6.2%. With a whistle, SpiroCall has a mean error of 8.3% for the four measures, and 7.3% for FEV1%. Although the whistle shows higher average error in lung function estimates, it is more consistent for people with lower lung function and produces fewer overestimations. The study was presented at the Association for Computing Machinery conference, held during May 2016 in San Jose (CA, USA).
"People have to manage chronic lung diseases for their entire lives, so there's a real need to have a device that allows patients to accurately monitor their condition at home without having to constantly visit a medical clinic,” said lead author Mayank Goel, MSc, a computer science and engineering doctoral student. “Because this project has been around for four years, we've been able to talk to a lot of patients about how they're able to use the technology, and that feedback has really helped us make smart improvement.”
Related Links:
University of Washington
Latest Health IT News
- AI System Detects and Quantifies Chronic Subdural Hematoma
- Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
- Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
- Voice-Driven AI System Enables Structured GI Procedure Documentation
- EMR-Based Tool Predicts Graft Failure After Kidney Transplant
- Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
- Smartwatches Could Detect Congestive Heart Failure
- Versatile Smart Patch Combines Health Monitoring and Drug Delivery
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read moreSurgical Techniques
view channel
New AI Tool Predicts Complications Before Lung Cancer Surgery
Lung cancer remains a leading cause of cancer mortality, and many surgical candidates present with complex comorbidities. Postoperative complications are common, making accurate and individualized risk... Read more
First Automated Insulin Delivery System Cleared for Type 1 Diabetes in Pregnancy
Managing glycemia during pregnancy complicated by type 1 diabetes requires tight targets and sustained time in a pregnancy-specific glucose range. Clinicians and patients often rely on automated insulin... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channelBusiness
view channel
Johnson & Johnson Launches AI-Driven Cardiac Mapping System
Johnson & Johnson has introduced the CARTOSOUND SONATA Module for the CARTO System at the Heart Rhythm Society (HRS) 2026 meeting in Chicago. The module uses artificial intelligence with the CARTO... Read more







